Page 7 - 2020年1月第31卷第2期

·药事管理·

基于专利申请视角的我国医药企业创新投入产出分析 Δ

#
＊
杨舒杰 ，武志昂（沈阳药科大学工商管理学院，沈阳 110016）
中图分类号 R95 文献标志码 A 文章编号 1001-0408（2020）02-0129-04
DOI 10.6039/j.issn.1001-0408.2020.02.01
摘 要 目的：为我国医药企业优化资源配置和精准投入提供依据。方法：检索中国知识产权网中我国医药行业发明专利申请数
量，分析我国医药行业专利申请主体的现状及结构。运用SPSS 23.0软件对我国医药企业发明专利申请数量与其研发经费投入情
况及主营业务收入进行投入产出的相关性分析。结果：我国医药行业发明专利申请量逐年递增，2000－2015年在我国申请医药
领域发明专利的国内申请主体共申请发明专利225 861件，国外申请主体共申请发明专利43 149件；国内申请主体的职务发明比
例仅为49.94％，国外申请主体的职务发明比例为96.79％。我国医药企业研发经费投入与其发明专利申请数量之间呈正相关，表
明我国医药行业的研发投入有利于促进发明专利的申请；医药企业主营业务收入与医药企业发明专利申请数量亦呈正相关，表明
医药企业发明专利申请数量的增加有效扩大了医药行业的经济规模。结论：我国医药行业发明专利主体的结构与国外相比亟待
调整，医药企业尚未成为发明专利的主要申请主体；医药企业持续的研发经费投入有效促进了发明专利的申请，扩大了医药行业
的经济规模。
关键词 发明专利；专利申请；医药企业；投入产出；研发

Analysis on Innovation Input-output in China’s Pharmaceutical Enterprises from the Perspective of Patent
Application
YANG Shujie，WU Zhi’ang（School of Business Administration，Shenyang Pharmaceutical University，Shenyang
110016，China）

ABSTRACT OBJECTIVE：To provide reference for optimizing resource allocation and precise investment of China’s pharma-
ceutical industry. METHODS：The number of invention patent applications in China’s pharmaceutical industry was searched from
China Intellectual Property Netwerk，and the status quo and structure of patent applications in China’s pharmaceutical industry
were analyzed. SPSS 23.0 software was used to analyze the input-output correlation of the number of invention patent applications
with R&D investment and main business income of pharmaceutical enterprises in China. RESULTS：The number of invention
patent applications in China’s pharmaceutical industry increased year by year. From 2000 to 2015，225 861 invention patents had
been applied by domestic applicants and 43 149 invention patents had been applied by foreign applicants in China；only 49.94％
domestic applicants applied for professional invention，while 96.79％ of foreign applicants applied for professional invention. There
was a positive correlation between the R&D expenditure of pharmaceutical enterprises and the number of invention patent
applications，which indicated that the R&D investment of pharmaceutical industry in China was beneficial to the invention patent
applications. The number of invention patent applications of pharmaceutical enterprises was also positively correlated with the main
business income，indicating that the increase of invention patent applications of pharmaceutical enterprises also effectively expanded
the economic scale of pharmaceutical industry. CONCLUSIONS： Compared with foreign countries， the structure of patent
applicants in domestic pharmaceutical industry needs to be adjusted urgently. Pharmaceutical enterprises have not yet become the
main applicants. The continuous R&D investment of pharmaceutical enterprises effectively promotes the application of invention
patent，expanded the economic scale of the pharmaceutical industry.
KEYWORDS Invention patent；Patent application；Pharmaceutical enterprise；Input-output；R&D

当前我国医药行业正处于由仿制药生产为主向“仿 有助于调整医药行业结构，增强我国医药行业的国际竞
[1]
创结合”转变的新时期，提高医药行业技术创新能力，将 争力和可持续发展能力 。根据技术创新理论，医药企
业发展技术创新活动有利于增强其市场竞争优势。专
Δ 基金项目：中国食品药品国际交流中心课题（No.2017-0-4-093）
利作为一种创造性智力成果，是新产品、新工艺的核心
＊副教授，博士研究生。研究方向：医药技术创新。E-mail：
技术，是技术创新活动产出的一种表现形式。随着医药
ysj1973@163.com
# 通信作者：教授，博士生导师。研究方向：药事管理。电话： 企业研发经费的不断投入，将会有新的技术创新成果不
024-23986543。E-mail：wuerla501@126.com 断涌现，而这些成果的规模可以通过专利申请数量的变

中国药房 2020年第31卷第2期 China Pharmacy 2020 Vol. 31 No. 2 ·129 ·